Urological management of indinavir-associated acute renal failure in HIV-positive patients

International Urology and Nephrology

Volumn 39, Issue 3, 2007, Pages 743-746

  Kalaitzis, C ^a   Passadakis, Ploumis ^a   Giannakopoulos, S ^a   Panagoutsos, S ^a   Mpantis, E ^a   Triantafyllidis, A ^a   Touloupidis, S ^a   Vargemezis, V ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

AIDS; HIV; Indinavir sulfate; Indinavir urolithiasis; Protease inhibitor

Indexed keywords

CREATININE; INDINAVIR; METHIONINE; UREA;

ACIDURIA; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CRYSTALLIZATION; CRYSTALLURIA; DISEASE ASSOCIATION; DRUG CAPSULE; DRUG EXCRETION; DRUG MECHANISM; DRUG SOLUBILITY; DRUG WITHDRAWAL; FEMALE; FLUID INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRATION; MALE; NEPHROTOXICITY; RISK FACTOR; SIDE EFFECT; STONE FORMATION; UREA BLOOD LEVEL; URETER STENT; URINE PH; UROLITHIASIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COMORBIDITY; FEMALE; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HUMANS; INDINAVIR; KIDNEY FAILURE, ACUTE; MALE; STENTS;

EID: 34548417235     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-9154-x     Document Type: Article

References (13)

1. Gendle DL, Stoller ML, Jarrett TW et al (1997) Protease inhibitor-induced urolithiasis. Urology 50:508-511
2. Crixivan R package insert. Merck and Co., lnc; U.S. Human health 1996
3. Salahuddin S, Hsu YS, Bucholz NP et al (2001) Is indinavir crystalluria anindicator for indinavir stone formation? AIDS 15(8):1079-1080
4. Grady BR, Munch LC, Hoven AD et al (1997) Urolithiasis associated with theprotease inhibitor indinavir. Urology 50(4):513-518
5. Chen IW, Vastag KJ, Lin JH (1995) High-performance liquid chromatographic determination of a potent and selective HIV protease inhibitor (L-735, 524) in rat, dog and monkey plasma. J chromatography B 672:111-117
6. Daudon M, Estepa L, Viard JP et al (1997) Urinary stones in HIV-1-positive patients treated with indinavir. The Lancet 349:1294-1295
7. Mascolini M (1996) The rolling uncertainties of antiprotease prescribing. J Int Assoc Physicians AIDS Care 2:6
8. Reilly RF, Tray K, Perazella MA (2001) Indinavir nephropathy revisited: a pattern of insidious renal failure with identifiable risk factors. Am J Kidney Dis 38(4):E23
9. Kopp JB, Miller KD, Mican JA (1997) Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 127:119-125
10. Izzedine H, Launay-Vacher V, Deray G (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45:5
11. Mouratoff JG, Tokumoto J, Olson JL, Chertow GM (2000) Acute renal failure with interstitial nephritis in a patient with AIDS. Am J Kidney Dis 35(3):557-561
12. Berns JS, Cohen RM, Silverman M, Turner J (1997) Acute renal failure due to indinavir crystalluria and nephrolithiasis: Report of two cases. Am J Kidney Dis 30:558-560
13. Kalaitzis C, Touloupidis S, Patris E, Lehrich K, Kuntz RM (2004) Indinavir-Urolithiasis bei HIV-positiven Patienten. Behandlung und Prophylaxe. Der Urologe A (43), Heft 2:168-171